Investing.com -- Hyperfine, Inc. (NASDAQ:HYPR)股价上涨4.6%,此前该公司在多伦多举行的2025年阿尔茨海默病协会国际会议上公布了其CARE PMR研究的早期令人鼓舞的结果。 这家健康技术公司报告称,其Swoop®系统(一种经FDA批准的AI驱动的便携式脑部MRI系统)在检测接受Lecanemab治疗的阿尔茨海默病患者的轻度至中度ARIA-E(脑水肿)...
Source LinkInvesting.com -- Hyperfine, Inc. (NASDAQ:HYPR)股价上涨4.6%,此前该公司在多伦多举行的2025年阿尔茨海默病协会国际会议上公布了其CARE PMR研究的早期令人鼓舞的结果。 这家健康技术公司报告称,其Swoop®系统(一种经FDA批准的AI驱动的便携式脑部MRI系统)在检测接受Lecanemab治疗的阿尔茨海默病患者的轻度至中度ARIA-E(脑水肿)...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.